Hetzer Medical Indonesia is trading at IDR 58.00, up 5.45%, with no confirmed company-specific catalyst identified for the November 6, 2026 move.

  • Recent interim financial-report filings are documented, but available information does not establish that they explain the price change.
  • The available sector context points lower and does not explain the stock’s rise; the reason remains unclear.